Wealth Alliance Has $201,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wealth Alliance cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 53.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,248 shares of the exchange traded fund’s stock after selling 2,578 shares during the quarter. Wealth Alliance’s holdings in SPDR S&P Biotech ETF were worth $201,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Resources Management Corp CT ADV lifted its holdings in shares of SPDR S&P Biotech ETF by 1,715.8% during the second quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock worth $29,000 after buying an additional 326 shares during the last quarter. Tyler Stone Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at $33,000. Compass Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $34,000. Fortis Capital Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $38,000. Finally, EPG Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 152.7% in the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after purchasing an additional 278 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.8 %

Shares of NYSEARCA XBI opened at $82.81 on Friday. The business has a fifty day simple moving average of $93.52 and a 200 day simple moving average of $84.21. The firm has a market capitalization of $6.43 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.